Inventor
BRUGNARA CARLO
US22 patents
⚠️ This page may combine multiple inventors who share the name “BRUGNARA CARLO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HARVARD COLLEGE
8 patentsUS5512591AApr 30, 1996
Treatments for diseases characterized by neovascularization
HARVARD COLLEGE57 citations96
US5633274AMay 27, 1997
Cancer treatments
HARVARD COLLEGE34 citations92
US5358959AOct 25, 1994
Methods for treating arteriosclerosis
HARVARD COLLEGE39 citations92
US5643936AJul 1, 1997
Treatments for diseases characterized by neovascularization
HARVARD COLLEGE7 citations73
US5556871ASep 17, 1996
Method for treating epithelial precancerous lesions with topical inidazoles
HARVARD COLLEGE8 citations68
US9678088B2Jun 13, 2017
Multiphase systems for diagnosis of sickle cell disease
HARVARD COLLEGE2 citations62
US5591763AJan 7, 1997
treatments for diseases characterized by neovascularization
HARVARD COLLEGE1 citations62
US7342038B2Mar 11, 2008
Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
HARVARD COLLEGE0 citations50
CHILDRENS MEDICAL CENTER
5 patentsUS6028103AFeb 22, 2000
Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
CHILDRENS MEDICAL CENTER36 citations90
US6331557B1Dec 18, 2001
Use of divalent cations for inhibiting erythrocyte dehydration in vivo
CHILDRENS MEDICAL CENTER10 citations65
US6800658B2Oct 5, 2004
Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation
CHILDRENS MEDICAL CENTER3 citations60
US6291449B1Sep 18, 2001
Use of 11-phenyl-dibenzazepine compounds to treat diarrhea or scours
CHILDRENS MEDICAL CENTER3 citations60
US7531573B2May 12, 2009
Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
CHILDRENS MEDICAL CENTER0 citations38
BETH ISRAEL HOSPITAL ASSOC INC
2 patentsUS5273992ADec 28, 1993
Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ
BETH ISRAEL HOSPITAL ASSOC INC32 citations91
US5441957AAug 15, 1995
Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ
BETH ISRAEL HOSPITAL ASSOC INC6 citations72
NUCHEM PHARMACEUTICALS INC
2 patentsUS6534497B1Mar 18, 2003
Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
NUCHEM PHARMACEUTICALS INC3 citations56
US6992079B2Jan 31, 2006
Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
NUCHEM PHARMACEUTICALS INC0 citations35